Description_x000D_ Application_x000D_ Finasteride has been used:_x000D_ • as a component of L-15 media to investigate the effects of finasteride exposure on brain, liver and testis tissues_x000D_ • in culture medium to treat tumor cells in vitro_x000D_ • as a positive control to treat benign prostatic hyperplasia (BPH)_x000D_ • to examine its effect on structural and molecular biology on the ventral prostate of senile mice_x000D_ Packaging_x000D_ 100 mg in glass bottle_x000D_ Biochem/physiol Actions_x000D_ Finasteride can reduce serum and scalp dihydrotestosterone (DHT) by preventing the transformation of testosterone to DHT. It is usually used to manage benign prostate hyperplasia and pattern hair loss in male. Finasteride possesses androgen-distracting properties._x000D_ Selective 5α-reductase inhibitor; antiandrogen._x000D_ Other Notes_x000D_ Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. F1293.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.